Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo. Ji Y, Harris MA, Newton LM, Harris TJ, et al. BMC Cancer 2024;24:1350.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ji Y, Harris MA, Newton LM, Harris TJ, et al. Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo. BMC Cancer 2024;24:1350.
PMID: 39497108